{"id":126891,"date":"2026-05-11T12:12:22","date_gmt":"2026-05-11T15:12:22","guid":{"rendered":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/"},"modified":"2026-05-11T12:12:25","modified_gmt":"2026-05-11T15:12:25","slug":"could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers","status":"publish","type":"post","link":"https:\/\/ubirataonline.com.br\/en\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/","title":{"rendered":"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?"},"content":{"rendered":"<p><\/p>\n<div>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START --><strong>Pfizer<\/strong> <span class=\"ticker\">(NYSE: PFE)<\/span> is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely lead to material revenue declines. It has fallen behind in the GLP-1 weight-loss drug race. And its payout ratio is worryingly high. Here&#8217;s why you might want to buy it anyway.<!-- HTML_TAG_END --><\/p>\n<h2 class=\"text article-heading-atom neo-font-heading-lg  yf-18d6y07\" id=\"\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><!-- HTML_TAG_START -->Wall Street is very downbeat on Pfizer<!-- HTML_TAG_END --> <\/h2>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->As the short list of problems above highlights, Pfizer is not hitting on all cylinders right now. Wall Street knows this, which helps explain why <a href=\"https:\/\/www.fool.com\/investing\/stock-market\/market-sectors\/healthcare\/pharmaceutical-stocks\/?utm_source=yahoo-host-full&amp;utm_medium=feed&amp;utm_campaign=article&amp;referring_guid=cffb2244-797a-42c9-82ce-194d84ef465a\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:the pharmaceutical company's;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;the pharmaceutical company'&quot;}\" class=\"link\">the pharmaceutical company&#8217;s<\/a> stock has fallen more than 50% from its 2021 highs. To be fair, that high was partly driven by over-enthusiastic investors, who priced in years of COVID vaccine revenues that didn&#8217;t materialize. But given the company&#8217;s long and successful history, investors still seem overly pessimistic about Pfizer&#8217;s future.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START --><em><strong>Will AI create the world&#8217;s first trillionaire?<\/strong>\u00a0Our team just released a report on the one little-known company, called an &#8220;Indispensable Monopoly&#8221; providing the critical technology Nvidia and Intel both need.\u00a0<a href=\"https:\/\/api.fool.com\/infotron\/infotrack\/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=25119b58-e50e-4231-a7e1-e13ff5ac9752&amp;url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fa-sa-ai-boom-nvidias%3Faid%3D10891%26source%3Disaediica0000069%26ftm_cam%3Dsa-ai-boom%26ftm_veh%3Dtop_incontent_pitch_feed_yahoo%26ftm_pit%3D18914&amp;utm_source=yahoo-host-full&amp;utm_medium=feed&amp;utm_campaign=article&amp;referring_guid=cffb2244-797a-42c9-82ce-194d84ef465a\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Continue \u00bb;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Continue \u00bb&quot;}\" class=\"link\"><span><strong>Continue \u00bb<\/strong><\/span><\/a><\/em><!-- HTML_TAG_END --><\/p>\n<figure data-testid=\"article-figure-image\" class=\"yf-750ceo\">\n<div class=\"image-container yf-lglytj\" style=\"--max-height: 540px;\">\n<div class=\"image-wrapper yf-lglytj\" style=\"--aspect-ratio: 960 \/ 540; --img-max-width: 960px;\"><\/div>\n<\/div><figcaption class=\"yf-750ceo\"><!-- HTML_TAG_START -->Image source: Getty Images.<!-- HTML_TAG_END -->  <\/figcaption><\/figure>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->After all, it is one of the world&#8217;s most respected pharmaceutical companies. And even after losing half its value, it remains an industry giant with a market cap of around $150 billion. Moreover, innovation tends to be lumpy, so patent expirations don&#8217;t always line up perfectly with new blockbuster drug launches. Given enough time, Pfizer is highly likely to pull out of the business funk it is in.<!-- HTML_TAG_END --><\/p>\n<h2 class=\"text article-heading-atom neo-font-heading-lg  yf-18d6y07\" id=\"\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><!-- HTML_TAG_START -->Some silver linings on Pfizer&#8217;s clouds<!-- HTML_TAG_END --> <\/h2>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->For example, after the company&#8217;s internal <a href=\"https:\/\/www.fool.com\/investing\/how-to-invest\/stocks\/glp-1-stocks\/?utm_source=yahoo-host-full&amp;utm_medium=feed&amp;utm_campaign=article&amp;referring_guid=cffb2244-797a-42c9-82ce-194d84ef465a\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:GLP-1 drug;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;GLP-1 drug&quot;}\" class=\"link\">GLP-1 drug<\/a> was dropped, it quickly pivoted and acquired a company with a more promising drug candidate. Pfizer isn&#8217;t out of the GLP-1 drug race just yet. Beyond weight-loss drugs, the company is still advancing new migraine and oncology candidates. Given the company&#8217;s successful history of drug development, it is highly likely that something will eventually click.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Meanwhile, management has stated clearly that it intends to maintain the dividend at the current level. Since dividends come out of cash flow and not earnings, it can support the dividend for a little while as it works to get earnings back into growth mode. More aggressive income investors should probably give the company the benefit of the doubt.<!-- HTML_TAG_END --><\/p>\n<h2 class=\"text article-heading-atom neo-font-heading-lg  yf-18d6y07\" id=\"\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><!-- HTML_TAG_START -->Pfizer&#8217;s turnaround offers Income and growth<!-- HTML_TAG_END --> <\/h2>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Buying Pfizer sets you up with a 6.5% dividend yield, which is roughly three-quarters of the way to the 10% return investors normally expect from stocks. Meanwhile, the sharp stock price decline positions investors for a rebound as Pfizer&#8217;s drug pipeline begins to bear fruit. That&#8217;s a recipe for investment riches, since buying now could mean both a robust income stream and capital appreciation for more intrepid dividend lovers.<!-- HTML_TAG_END --><\/p>\n<\/p><\/div>\n<div style=\"display: none\" data-testid=\"read-more\">\n<h2 class=\"text article-heading-atom neo-font-heading-lg  yf-18d6y07\" id=\"\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\"><!-- HTML_TAG_START -->Should you buy stock in Pfizer right now?<!-- HTML_TAG_END --> <\/h2>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Before you buy stock in Pfizer, consider this:<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->The <em>Motley Fool Stock Advisor<\/em> analyst team just identified what they believe are the\u00a0<strong><a href=\"https:\/\/api.fool.com\/infotron\/infotrack\/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=101603b9-85b8-4efd-88ae-f0f4ad62bbea&amp;url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-sa-bbn-dyn-headline%3Faid%3D11234%26source%3Disaeditxt0001181%26company%3DPfizer%26ftm_cam%3Dsa-bbn-evergreen%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D18781&amp;utm_source=yahoo-host-full&amp;utm_medium=feed&amp;utm_campaign=article&amp;referring_guid=cffb2244-797a-42c9-82ce-194d84ef465a\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:10 best stocks;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;10 best stocks&quot;}\" class=\"link\">10 best stocks<\/a><\/strong> for investors to buy now\u2026 and Pfizer wasn\u2019t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Consider when <strong>Netflix<\/strong> made this list on December 17, 2004&#8230; if you invested $1,000 at the time of our recommendation,\u00a0<strong>you\u2019d have $471,827<\/strong>!* Or when <strong>Nvidia<\/strong> made this list on April 15, 2005&#8230; if you invested $1,000 at the time of our recommendation, <strong>you\u2019d have $1,319,291<\/strong>!*<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Now, it\u2019s worth noting\u00a0<em>Stock Advisor\u2019s<\/em> total average return is 986<span>% \u2014 a market-crushing outperformance compared to 207% for the S&amp;P 500.\u00a0<strong><span>Don&#8217;t miss the latest top 10 list, available with\u00a0<em>Stock Advisor<\/em>, and join an investing community built by individual investors for individual investors.<\/span><\/strong><\/span><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START --><a class=\"link\" href=\"https:\/\/api.fool.com\/infotron\/infotrack\/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=101603b9-85b8-4efd-88ae-f0f4ad62bbea&amp;url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-sa-bbn-dyn-headline%3Faid%3D11234%26source%3Disaeditxt0001181%26company%3DPfizer%26ftm_cam%3Dsa-bbn-evergreen%26ftm_pit%3D18781%26ftm_veh%3Darticle_pitch_feed_yahoo%26company%3DPfizer&amp;utm_source=yahoo-host-full&amp;utm_medium=feed&amp;utm_campaign=article&amp;referring_guid=cffb2244-797a-42c9-82ce-194d84ef465a\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:See the 10 stocks \u00bb;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;See the 10 stocks \u00bb&quot;}\"><strong>See the 10 stocks \u00bb<\/strong><\/a><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START --><em>*Stock Advisor returns as of May 9, 2026. <\/em><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START --><em><a href=\"https:\/\/www.fool.com\/author\/2110\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Reuben Gregg Brewer;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Reuben Gregg Brewer&quot;}\" class=\"link\">Reuben Gregg Brewer<\/a> has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a <a href=\"https:\/\/www.fool.com\/legal\/fool-disclosure-policy\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:disclosure policy;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;disclosure policy&quot;}\" class=\"link\">disclosure policy<\/a>.<\/em><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START --><a href=\"https:\/\/www.fool.com\/investing\/2026\/05\/09\/could-buying-this-beaten-down-healthcare-stock-mak\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?&quot;}\" class=\"link\">Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?<\/a> was originally published by The Motley Fool<!-- HTML_TAG_END --><\/p>\n<\/p><\/div>\n<p><a href=\"https:\/\/finance.yahoo.com\/sectors\/healthcare\/articles\/could-buying-beaten-down-healthcare-163500394.html\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Pfizer (NYSE: PFE) is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely lead to material revenue declines. It has fallen behind in the GLP-1 weight-loss drug race. And its payout ratio is worryingly high. Here&#8217;s why you might want to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":126892,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAow2JLhCw:productID":"","_gspb_post_css":"","maa_idioma":"","maa_pais":"","footnotes":""},"categories":[1],"tags":[34815,9546,13596,6748,13570,5417],"class_list":["post-126891","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ubirata","tag-beatendown","tag-buying","tag-healthcare","tag-recovers","tag-rich","tag-stock"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers? - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!<\/title>\n<meta name=\"description\" content=\"Pfizer (NYSE: PFE) is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ubirataonline.com.br\/en\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?\" \/>\n<meta property=\"og:description\" content=\"Pfizer (NYSE: PFE) is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ubirataonline.com.br\/en\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/\" \/>\n<meta property=\"og:site_name\" content=\"Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/portalubirataonline\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/portalubirataonline\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-11T15:12:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-11T15:12:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@x.com\/ubirataonline\" \/>\n<meta name=\"twitter:site\" content=\"@ubirataonline\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/\"},\"author\":{\"name\":\"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#\\\/schema\\\/person\\\/372f87bbd3fdd79b8556b84c98d0bc1c\"},\"headline\":\"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?\",\"datePublished\":\"2026-05-11T15:12:22+00:00\",\"dateModified\":\"2026-05-11T15:12:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/\"},\"wordCount\":671,\"publisher\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg\",\"keywords\":[\"BeatenDown\",\"buying\",\"healthcare\",\"recovers\",\"Rich\",\"stock\"],\"articleSection\":[\"Ubirat\u00e3\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/\",\"name\":\"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers? - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg\",\"datePublished\":\"2026-05-11T15:12:22+00:00\",\"dateModified\":\"2026-05-11T15:12:25+00:00\",\"description\":\"Pfizer (NYSE: PFE) is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg\",\"contentUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg\",\"width\":1200,\"height\":675,\"caption\":\"Image source: Getty Images.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ubirataonline.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#website\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/\",\"name\":\"Ubirat\u00e3 Online Not\u00edcias\",\"description\":\"Not\u00edcias de Ubirat\u00e3, regi\u00e3o, Brasil e mundo, com informa\u00e7\u00e3o atualizada e compromisso com o leitor.\",\"publisher\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#organization\"},\"alternateName\":\"Ubirat\u00e3 Online\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ubirataonline.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#organization\",\"name\":\"Ubirat\u00e3 Online Not\u00edcias\",\"alternateName\":\"Ubirat\u00e3 Online\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/\",\"logo\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#local-main-organization-logo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/portalubirataonline\",\"https:\\\/\\\/x.com\\\/ubirataonline\",\"https:\\\/\\\/mastodon.social\\\/@ubirataonline\",\"https:\\\/\\\/www.facebook.com\\\/groups\\\/311144672285604\",\"https:\\\/\\\/www.facebook.com\\\/UBTAOnline\",\"https:\\\/\\\/www.instagram.com\\\/portalubirataonline\\\/\",\"https:\\\/\\\/twitter.com\\\/ubirataonline\"],\"description\":\"Somos um portal de not\u00edcias independente, criado em 5 de janeiro de 2009, com o objetivo de informar, conectar e valorizar a nossa comunidade de Ubirat\u00e3 e toda aregi\u00e3o. Com conte\u00fado atualizado, confi\u00e1vel e relevante, o Ubirat\u00e3 Online \u00e9 o seu espa\u00e7o para ficar por dentro dos principais acontecimentos locais, regionais, Brasil, Mundo e de interesse geral. Nosso compromisso \u00e9 com a verdade, a transpar\u00eancia e o respeito ao leitor.\",\"legalName\":\"UBIRATA ONLINE NOT\u00cdCIAS\",\"foundingDate\":\"2009-01-05\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"1\",\"maxValue\":\"10\"},\"publishingPrinciples\":\"https:\\\/\\\/ubirataonline.com.br\\\/faq\\\/\",\"address\":{\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#local-main-place-address\"},\"geo\":{\"@type\":\"GeoCoordinates\",\"latitude\":\"-24.5361401\",\"longitude\":\"-52.9921776\"},\"telephone\":[\"+5544998308235\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"email\":\"contato@ubirataonline.com.br\"},\"openingHoursSpecification\":{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\",\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"23:59\"},\"email\":\"contato@ubirataonline.com.br\",\"vatID\":\"47.621.418\\\/0001-80\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/#\\\/schema\\\/person\\\/372f87bbd3fdd79b8556b84c98d0bc1c\",\"name\":\"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO\",\"pronouns\":\"Ele\",\"description\":\"Desde 2003 trabalhando com not\u00edcias.\",\"sameAs\":[\"http:\\\/\\\/ubirataoline.com.br\",\"https:\\\/\\\/www.facebook.com\\\/portalubirataonline\",\"https:\\\/\\\/www.instagram.com\\\/ubirataonline_oficial\",\"https:\\\/\\\/x.com\\\/x.com\\\/ubirataonline\"],\"honorificPrefix\":\"Mr.\",\"honorificSuffix\":\"MD\",\"birthDate\":\"1980-06-16\",\"gender\":\"masculino\",\"award\":[\"V\u00e1rios pr\u00eamios de melhor portal da cidade\"],\"jobTitle\":\"Diretor\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/en\\\/author\\\/ubirataonline\\\/\"},{\"@type\":\"PostalAddress\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#local-main-place-address\",\"streetAddress\":\"Rua dos Coqueiros, 104 - Bairro Boa Vista, Rua dos Coqueiros, 104 Bairro Boa Vista\",\"addressLocality\":\"UBIRATA\",\"postalCode\":\"85440-000\",\"addressRegion\":\"PR\",\"addressCountry\":\"BR\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ubirataonline.com.br\\\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\\\/#local-main-organization-logo\",\"url\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logoubirataonline-1.webp\",\"contentUrl\":\"https:\\\/\\\/ubirataonline.com.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logoubirataonline-1.webp\",\"width\":500,\"height\":500,\"caption\":\"Ubirat\u00e3 Online Not\u00edcias\"}]}<\/script>\n<meta name=\"geo.placename\" content=\"UBIRATA\" \/>\n<meta name=\"geo.position\" content=\"-24.5361401;-52.9921776\" \/>\n<meta name=\"geo.region\" content=\"Brazil\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers? - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!","description":"Pfizer (NYSE: PFE) is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ubirataonline.com.br\/en\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/","og_locale":"en_US","og_type":"article","og_title":"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?","og_description":"Pfizer (NYSE: PFE) is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely","og_url":"https:\/\/ubirataonline.com.br\/en\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/","og_site_name":"Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!","article_publisher":"https:\/\/www.facebook.com\/portalubirataonline","article_author":"https:\/\/www.facebook.com\/portalubirataonline","article_published_time":"2026-05-11T15:12:22+00:00","article_modified_time":"2026-05-11T15:12:25+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg","type":"image\/jpeg"}],"author":"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO","twitter_card":"summary_large_image","twitter_creator":"@x.com\/ubirataonline","twitter_site":"@ubirataonline","twitter_misc":{"Written by":"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#article","isPartOf":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/"},"author":{"name":"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO","@id":"https:\/\/ubirataonline.com.br\/#\/schema\/person\/372f87bbd3fdd79b8556b84c98d0bc1c"},"headline":"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?","datePublished":"2026-05-11T15:12:22+00:00","dateModified":"2026-05-11T15:12:25+00:00","mainEntityOfPage":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/"},"wordCount":671,"publisher":{"@id":"https:\/\/ubirataonline.com.br\/#organization"},"image":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#primaryimage"},"thumbnailUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg","keywords":["BeatenDown","buying","healthcare","recovers","Rich","stock"],"articleSection":["Ubirat\u00e3"],"inLanguage":"en-US","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/ubirataonline.com.br\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/","url":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/","name":"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers? - Ubirat\u00e3 Online Not\u00edcias - A realidade ao seu alcance!","isPartOf":{"@id":"https:\/\/ubirataonline.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#primaryimage"},"image":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#primaryimage"},"thumbnailUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg","datePublished":"2026-05-11T15:12:22+00:00","dateModified":"2026-05-11T15:12:25+00:00","description":"Pfizer (NYSE: PFE) is in a difficult spot right now. It has a number of blockbuster drugs nearing the end of their patent protection, which will likely","breadcrumb":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#primaryimage","url":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg","contentUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/05\/Could-Buying-This-Beaten-Down-Healthcare-Stock-Make-You-Rich-If.jpeg","width":1200,"height":675,"caption":"Image source: Getty Images."},{"@type":"BreadcrumbList","@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ubirataonline.com.br\/"},{"@type":"ListItem","position":2,"name":"Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?"}]},{"@type":"WebSite","@id":"https:\/\/ubirataonline.com.br\/#website","url":"https:\/\/ubirataonline.com.br\/","name":"Ubirat\u00e3 Online Not\u00edcias","description":"Not\u00edcias de Ubirat\u00e3, regi\u00e3o, Brasil e mundo, com informa\u00e7\u00e3o atualizada e compromisso com o leitor.","publisher":{"@id":"https:\/\/ubirataonline.com.br\/#organization"},"alternateName":"Ubirat\u00e3 Online","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ubirataonline.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/ubirataonline.com.br\/#organization","name":"Ubirat\u00e3 Online Not\u00edcias","alternateName":"Ubirat\u00e3 Online","url":"https:\/\/ubirataonline.com.br\/","logo":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#local-main-organization-logo"},"image":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#local-main-organization-logo"},"sameAs":["https:\/\/www.facebook.com\/portalubirataonline","https:\/\/x.com\/ubirataonline","https:\/\/mastodon.social\/@ubirataonline","https:\/\/www.facebook.com\/groups\/311144672285604","https:\/\/www.facebook.com\/UBTAOnline","https:\/\/www.instagram.com\/portalubirataonline\/","https:\/\/twitter.com\/ubirataonline"],"description":"Somos um portal de not\u00edcias independente, criado em 5 de janeiro de 2009, com o objetivo de informar, conectar e valorizar a nossa comunidade de Ubirat\u00e3 e toda aregi\u00e3o. Com conte\u00fado atualizado, confi\u00e1vel e relevante, o Ubirat\u00e3 Online \u00e9 o seu espa\u00e7o para ficar por dentro dos principais acontecimentos locais, regionais, Brasil, Mundo e de interesse geral. Nosso compromisso \u00e9 com a verdade, a transpar\u00eancia e o respeito ao leitor.","legalName":"UBIRATA ONLINE NOT\u00cdCIAS","foundingDate":"2009-01-05","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"1","maxValue":"10"},"publishingPrinciples":"https:\/\/ubirataonline.com.br\/faq\/","address":{"@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#local-main-place-address"},"geo":{"@type":"GeoCoordinates","latitude":"-24.5361401","longitude":"-52.9921776"},"telephone":["+5544998308235"],"contactPoint":{"@type":"ContactPoint","email":"contato@ubirataonline.com.br"},"openingHoursSpecification":{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday","Saturday","Sunday"],"opens":"00:00","closes":"23:59"},"email":"contato@ubirataonline.com.br","vatID":"47.621.418\/0001-80"},{"@type":"Person","@id":"https:\/\/ubirataonline.com.br\/#\/schema\/person\/372f87bbd3fdd79b8556b84c98d0bc1c","name":"REDA\u00c7\u00c3O: UBIRAT\u00c3 ONLINE - F\u00c1BIO AUGUSTO CELESTINO","pronouns":"Ele","description":"Desde 2003 trabalhando com not\u00edcias.","sameAs":["http:\/\/ubirataoline.com.br","https:\/\/www.facebook.com\/portalubirataonline","https:\/\/www.instagram.com\/ubirataonline_oficial","https:\/\/x.com\/x.com\/ubirataonline"],"honorificPrefix":"Mr.","honorificSuffix":"MD","birthDate":"1980-06-16","gender":"masculino","award":["V\u00e1rios pr\u00eamios de melhor portal da cidade"],"jobTitle":"Diretor","url":"https:\/\/ubirataonline.com.br\/en\/author\/ubirataonline\/"},{"@type":"PostalAddress","@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#local-main-place-address","streetAddress":"Rua dos Coqueiros, 104 - Bairro Boa Vista, Rua dos Coqueiros, 104 Bairro Boa Vista","addressLocality":"UBIRATA","postalCode":"85440-000","addressRegion":"PR","addressCountry":"BR"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ubirataonline.com.br\/could-buying-this-beaten-down-healthcare-stock-make-you-rich-if-it-recovers\/#local-main-organization-logo","url":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/06\/logoubirataonline-1.webp","contentUrl":"https:\/\/ubirataonline.com.br\/wp-content\/uploads\/2026\/06\/logoubirataonline-1.webp","width":500,"height":500,"caption":"Ubirat\u00e3 Online Not\u00edcias"}]},"geo.placename":"UBIRATA","geo.position":{"lat":"-24.5361401","long":"-52.9921776"},"geo.region":"Brazil"},"_links":{"self":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/posts\/126891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/comments?post=126891"}],"version-history":[{"count":0,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/posts\/126891\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/media\/126892"}],"wp:attachment":[{"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/media?parent=126891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/categories?post=126891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ubirataonline.com.br\/en\/wp-json\/wp\/v2\/tags?post=126891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}